Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients (Q46829214)

25 December 2017

title

Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients (English)

1 reference

25 December 2017

author name string

Wendy Chrapko

1

1 reference

25 December 2017

Paul Jurasz

2

1 reference

25 December 2017

Marek W Radomski

3

1 reference

25 December 2017

Stephen L Archer

4

1 reference

25 December 2017

Stephen C Newman

5

1 reference

25 December 2017

Glen Baker

6

1 reference

25 December 2017

Nathalie Lara

7

1 reference

25 December 2017

Jean-Michel Le Mellédo

8

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

25 December 2017

published in

Neuropsychopharmacology

1 reference

25 December 2017

volume

31

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

1286-1293

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300961

exact match

0 references

cites work

Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Pathogenetic concepts of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Endothelial dysfunction in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Detection of endothelial dysfunction with brachial artery ultrasound scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Nitric oxide released from activated platelets inhibits platelet recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Sertraline treatment of major depression in patients with acute MI or unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Depression and cardiovascular disease: mechanisms of interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Paroxetine-Induced Increase in Metabolic End Products of Nitric Oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Endothelium and the lipid metabolism: the current understanding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Platelet reactivity in depressed patients treated with paroxetine: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Inhibitory effect of glucocorticoid on coronary artery endothelial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Cardiovascular effects of fluoxetine in depressed patients with heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Treating depression in patients with ischaemic heart disease: which agents are best to use and to avoid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Epidemiology of comorbid coronary artery disease and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Primary endothelial dysfunction: atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Nitric oxide as a challenge for the clinical chemistry laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Measurement of nitric oxide in biological models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Impaired Platelet Production of Nitric Oxide Predicts Presence of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Increased cholesterol levels during paroxetine administration in healthy men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Cortisol inhibits cholinergic vasodilation in the human forearm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

An improved method for washing of human platelets with prostacyclin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Abnormal brachial artery flow-mediated vasodilation in young adults with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Treatment of depression in patients with heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300961

1 reference

25 December 2017

Dimensions Publication ID

1028699320

0 references

1 reference

25 December 2017